Pedestrian injuries, heart disease, and Type 2 diabetes (FOI)Pedestrian injuries, heart disease, and Type 2 diabetes (FOI)
Produced by the Freedom of Information officeAuthored by Government of Jersey and published on
22 November 2019.Prepared internally, no external costs.
βRequest
A
Since records began, and broken down into year by year, how many confirmed reports have there been of injuries to pedestrians involving by a motorised vehicle?
B
Since records began, and broken down into year by year, how many confirmed reports have there been of deaths of pedestrians involving by a motorised vehicle?
C
Since records began, and broken down into year by year, how many confirmed reports have there been of injuries to pedestrians by a bicycle?
D
Since records began, and broken down into year by year, how many confirmed reports have there been of death of a pedestrian by a bicycle?
E
How many deaths have there been in each of the past five years of records through heart or heart complications in Jersey?
Please break it down to the following:
110-I15 Hypertensive diseases
126-I28 Pulmonary heart disease and diseases of pulmonary circulation
I60-I69 Cerebrovascular diseases
I70-I79 Diseases of arteries, arterioles and capillaries
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified
F
How many deaths have there been in each of the past five years of records through diabetes type 2 complications?
G
In each of the past five years how much has been spent of the healthcare budget on those suffering heart and heart related diseases?
H
In each of the past five years how much has been spent of the healthcare budget
on those suffering from Type 2 diabetes?
I
What is the estimated cost per year of treating a Type 2 diabetes patient?
Response
A-D
βPedestrian RTC β | β βInjuries | β βDeaths |
βA. Motorised Vehicle | βC. Cycle | βB. Motorised Vehicle | βD. Cycle |
β2008* | β49 | 2β | β | β |
β2009 | 56β | β2 | β | β |
β2010 | 46β | 0β | β | β |
β2011 | 36β | 1β | β | β |
β2012 | β43 | 1 | 1β | β |
β2013 | 48β | 2β | β | β |
β2014 | 47β | 1β | β | β |
β2015 | 51β | 2β | β | β |
β2016 | 42β | 6β | 1β | β |
β2017 | 42β | 2β | 1β | β |
β2018 | 46β | 2β | β | β |
β2019** | 30β | 4β | β | β |
*Records are not held prior to 2008
**Figures accurate as of 16 September 2019
E
Number of deaths, by underlying cause, are given by year below. Counts less than 5 have been suppressed and all other counts have been rounded to the nearest 5 to prevent disclosure of individuals personal information.
β | β2007 | 2008β | 2009β | 2010β | 2011β | 2012β | 2013β | 2014β | 2015β | 2016 | 2017 |
β110-I15 Hypertensive diseases | β20 | 20β | 20β | 10β | -β | 5β | -β | 10β | 10β | 10β | 15β |
β126-I28 Pulmonary heart disease and diseases of pulmonary circulation | 5β | -β | -β | -β | -β | -β | -β | -β | -β | -β | -β |
βI60-I69 Cerebrovascular diseases | 45β | 50β | 55β | 60β | 60β | 70β | 55β | 40β | 45β | 55β | 55β |
βI70-I79 Diseases of arteries, arterioles and capillaries | β20 | β25 | 30β | 15β | 10β | 10β | 10β | 15β | 10β | 15β | 5β |
βI80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | β5 | β10 | β5 | β- | 5β | -β | -β | -β | 5β | -β | -β |
F
Across the time period 2007-2017, on average there were 4.6 deaths each year where the underlying cause of death was recorded as 'Type 2 diabetes mellitus, with or without complications'.
In addition, there were, on average, 7.3 deaths each year where the underlying cause of death was recorded as 'Unspecific diabetes mellitus' - where it cannot be determined from the available information whether these should be classified as Type 1 or Type 2 diabetes.
It is not possible to break the data down by each year due to the small numbers making it potentially disclosive on an annual basis. Article 25 (Personal information) of the Freedom of Information (Jersey) Law 2011 has been applied. However, the year to year variation is not statistically significantly different to what would be expected from random fluctuations.
G
βBusiness Unit | βProportion of Business Unit expenditure | β2014 (Β£) | β2015 (Β£) | β2016 (Β£) | β2017 (Β£) | β2018 (Β£) |
βInflight co-ordinator | β40% | β45,629 | β49,724 | β48,502 | β51,215 | β53,699 |
βCharter flights | β40% | β438,130 | β446,490 | β381,161 | β397,604 | β482,977 |
βCardiology | β100% | β517,039 | β532,835 | β525,315 | β692,353 | β856,711 |
βUK referrals | β | β1,181,342 | β1,411,366 | β1,791,802 | β1,437,902 | β1,245,794 |
βClinical investigations (50% of everything but cardiac appliances) | β50% | β330,242 | β358,036 | β356,250 | β382,070 | β377,229 |
βClinical investigations (cardiac appliances only) | β | β213,639 | β237,438 | β215,116 | β271,164 | β228,843 |
H
It is estimated that 85% of the budget allocated to diabetes has been spent on treating Type 2 diabetes. The figures below represent the estimated costs per annum. These figures do not include the cost of inpatient hospital stays.
βYear | βAmount |
β2014 | βΒ£825,820 |
β2015 | βΒ£904,192 |
β2016 | βΒ£871,920 |
β2017 | βΒ£1,015,050 |
β2018 | βΒ£1,188,212 |
I
Information is not recorded on a cost per patient basis. To retrieve this information would require in depth analysis of each patientβs records, therefore it is not possible to break down the costs per individual within the time restraints of the Freedom of Information (Jersey) Law 2011.
Articles applied
Article 16 A scheduled public authority may refuse to supply information if cost excessive
(1) A scheduled public authority that has been requested to supply information may refuse to supply the information if it estimates that the cost of doing so would exceed an amount determined in the manner prescribed by Regulations.
Regulation 2 (1) of the Freedom of Information (Costs) (Jersey) Regulations 2014 allows an authority to refuse a request for information where the estimated cost of dealing with the request would exceed the specified amount of the cost limit of Β£500. This is the estimated cost of one person spending 12.5 working hours in determining whether the department holds the information, locating, retrieving and extracting the information.
Article 25 Personal information
(1) Information is absolutely exempt information if it constitutes personal data of which the applicant is the data subject as defined in the Data Protection (Jersey) Law 2018.
(2) Information is absolutely exempt information if β
(a) it constitutes personal data of which the applicant is not the data subject as defined in the Data Protection (Jersey) Law 2018; and
(b) its supply to a member of the public would contravene any of the data protection principles, as defined in that Law.
(3) In determining for the purposes of this Article whether the lawfulness principle in Article 8(1)(a) of the Data Protection (Jersey) Law 2018 would be contravened by the disclosure of information, paragraph 5(1) of Schedule 2 to that Law (legitimate interests) is to be read as if sub-paragraph (b) (which disapplies the provision where the controller is a public authority) were omitted.